Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 413097, 8 pages
http://dx.doi.org/10.1155/2015/413097
Research Article

Pantoprazole Decreases Cell Viability and Function of Human Osteoclasts In Vitro

Experimental Trauma Surgery, Department of Trauma Surgery, Klinikum Rechts der Isar, Technical University Munich, Ismaninger Straße 22, 81675 Munich, Germany

Received 28 August 2014; Revised 7 November 2014; Accepted 12 November 2014

Academic Editor: Frank Hildebrand

Copyright © 2015 Markus Prause et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. O. Katz, L. B. Gerson, and M. F. Vela, “Guidelines for the diagnosis and management of gastroesophageal reflux disease,” The American Journal of Gastroenterology, vol. 108, no. 3, pp. 308–328, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. L. Wallace, “Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?” Physiological Reviews, vol. 88, no. 4, pp. 1547–1565, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Alhazzani, F. Alenezi, R. Z. Jaeschke, P. Moayyedi, and D. J. Cook, “Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis,” Critical Care Medicine, vol. 41, no. 3, pp. 693–705, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Chubineh and J. Birk, “Proton pump inhibitors: the good, the bad, and the unwanted,” Southern Medical Journal, vol. 105, no. 11, pp. 613–618, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Ye, H. Liu, C. Wu et al., “Proton pump inhibitors therapy and risk of hip fracture: a systematic review and meta-analysis,” European Journal of Gastroenterology & Hepatology, vol. 23, no. 9, pp. 794–800, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. W. Yu, T. Blackwell, K. E. Ensrud et al., “Acid-suppressive medications and risk of bone loss and fracture in older adults,” Calcified Tissue International, vol. 83, no. 4, pp. 251–259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Ngamruengphong, G. I. Leontiadis, S. Radhi, A. Dentino, and K. Nugent, “Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies,” The American Journal of Gastroenterology, vol. 106, no. 7, pp. 1209–1218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. E. Targownik and W. D. Leslie, “The relationship among proton pump inhibitors, bone disease and fracture,” Expert Opinion on Drug Safety, vol. 10, no. 6, pp. 901–912, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-X. Yang, J. D. Lewis, S. Epstein, and D. C. Metz, “Long-term proton pump inhibitor therapy and risk of hip fracture,” The Journal of the American Medical Association, vol. 296, no. 24, pp. 2947–2953, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. L. Insogna, “The effect of proton pump-inhibiting drugs on mineral metabolism,” The American Journal of Gastroenterology, vol. 104, supplement 2, pp. S2–S4, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Vestergaard, L. Rejnmark, and L. Mosekilde, “Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture,” Calcified Tissue International, vol. 79, no. 2, pp. 76–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Prause, C. Seeliger, M. Unger, M. van Griensven, and A. T. Haug, “Pantoprazole increases cell viability and function of primary human osteoblasts in vitro,” Injury, vol. 45, no. 8, pp. 1156–1164, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Tuukkanen and H. K. Väänänen, “Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro,” Calcified Tissue International, vol. 38, no. 2, pp. 123–125, 1986. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Gruber, “Molecular and cellular basis of bone resorption,” Wiener Medizinische Wochenschrift, 2014. View at Publisher · View at Google Scholar
  15. J. P. Mattsson, K. Väänänen, B. Wallmark, and P. Lorentzon, “Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H+-translocating ATPases,” Biochimica et Biophysica Acta: Biomembranes, vol. 1065, no. 2, pp. 261–268, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. K. B. Filion, D. Chateau, L. E. Targownik et al., “Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis,” Gut, vol. 63, pp. 552–558, 2014. View at Google Scholar
  17. K. A. Yearsley, L. J. Gilby, A. V. Ramadas, E. M. Kubiak, D. L. Fone, and M. C. Allison, “Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea,” Alimentary Pharmacology and Therapeutics, vol. 24, no. 4, pp. 613–619, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. R. Sheraly, D. Lickorish, F. Sarraf, and J. E. Davies, “Use of gastrointestinal proton pump inhibitors to regulate osteoclast-mediated resorption of calcium phosphate cements in vivo,” Current Drug Delivery, vol. 6, no. 2, pp. 192–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. J. Hyun, H. J. Chun, B. Keum et al., “Effect of omeprazole on the expression of transcription factors in osteoclasts and osteoblasts,” International Journal of Molecular Medicine, vol. 26, no. 6, pp. 877–883, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Zaidi, “Modularity of osteoclast behaviour and “model-specific” inhibition of osteoclast function,” Bioscience Reports, vol. 10, no. 6, pp. 547–556, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. L. E. Targownik, L. M. Lix, C. J. Metge, H. J. Prior, S. Leung, and W. D. Leslie, “Use of proton pump inhibitors and risk of osteoporosis-related fractures,” Canadian Medical Association Journal, vol. 179, no. 4, pp. 319–326, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Mizunashi, Y. Furukawa, K. Katano, and K. Abe, “Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans,” Calcified Tissue International, vol. 53, no. 1, pp. 21–25, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Costa-Rodrigues, S. Reis, S. Teixeira, S. Lopes, and M. H. Fernandes, “Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity,” The FEBS Journal, vol. 280, no. 20, pp. 5052–5064, 2013. View at Publisher · View at Google Scholar · View at Scopus